|Capital stock||4,449,844,000 yen|
|Common shares authorized||44,000,000 shares|
|Common shares issued||22,547,140 shares （including 152,519 treasury shares）|
|Stock exchange listings||Tokyo Stock Exchange First Section|
|Stock trading unit||100 shares|
|Shareholders||11,434 （increase of 401 since the end of the previous fiscal year）|
|Shareholder name||Number of shares held (shares)||Percentage of total shares outstanding|
|Nippon Suisan Kaisha, Ltd.||12,106,202||54.05|
|Japan Trustee Services Bank, Ltd. (Trust Account)||448,200||2.00|
|The Master Trust Bank of Japan, Ltd. (Trust Account)||332,800||1.48|
|Nissui Logistics Corporation||273,053||1.21|
|Nissui Pharmaceutical Minori Shareholders’ Association||249,054||1.11|
|Sompo Japan Nipponkoa Insurance Inc.||199,500||0.89|
|Japan Trustee Services Bank, Ltd. (Trust Account 5)||168,100||0.75|
|DFA INTL SMALL CAP VALUE PORTFOLIO||127,000||0.56|
|Japan Trustee Services Bank, Ltd. (Trust Account 1)||115,500||0.51|
|T2 Capital., Ltd.||100,000||0.44|
Note: The Company is holding 152,519 treasury shares (0.67% of total shares issued), but is not included in the above list of major shareholders.
At present, Nissui Pharmaceutical is not included in any stock indices.
At present, Nissui Pharmaceutical has no outstanding bonds and has not obtained a credit rating.
At present, Nissui Pharmaceutical has no history of having engaged in share or capital transfers.